H, Y., & VC, W. (2017). Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin. Dove Medical Press.
Chicago Style (17th ed.) CitationH, Yu, and Woo VC. Emerging Use of Combination Therapies for the Management of Type 2 Diabetes – Focus on Saxagliptin and Dapagliflozin. Dove Medical Press, 2017.
MLA (8th ed.) CitationH, Yu, and Woo VC. Emerging Use of Combination Therapies for the Management of Type 2 Diabetes – Focus on Saxagliptin and Dapagliflozin. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.